Acquirer
Otsuka Holdings
Otsuka Holdings appears as the named buyer in 5 recorded transactions between 2017 and 2024, most often in healthcare & life sciences and food & beverage. 2 of those were bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Otsuka Holdings has bought
Every recorded transaction where Otsuka Holdings is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Jnana Therapeutics | Healthcare & Life Sciences | Polaris Partners PE | 2024-08-01 | $800m |
| iBio - Preclinical PD-1 Agonist Antibody Program | Healthcare & Life Sciences | iBio | 2024-02-25 | $53m |
| Visterra | Healthcare & Life Sciences | — | 2018-07-11 | $430m |
| Daiya Foods | Food & Beverage | Stockton Road Capital PE | 2017-07-27 | $308m |
| Neurovance | Healthcare & Life Sciences | — | 2017-03-03 | $100m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.